Oncoville Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 4 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 7.61 M
- Revenue Growth 180.43%
- Profit Growth 558.56%
- Ebitda 749.84%
- Net Worth 637.61%
- Total Assets 77.33%
About Oncoville
Oncoville Private Limited (OPL) is a Private Limited Indian Non-Government Company incorporated in India on 11 May 2020 (Four years and nine months 15 days old ). Its registered office is in Bangaluru, Karnataka, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹7.61 M.
Anilkumar Gowda, Raje Manjula, and Raje Usha serve as directors at the Company.
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U85100KA2020PTC134107
- Company No.
134107
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 May 2020
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Who are the key members and board of directors at Oncoville?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anilkumar Gowda  | Director | 11-May-2020 | Current |
| Raje Manjula | Director | 11-May-2020 | Current |
| Raje Usha | Director | 11-May-2020 | Current |
Financial Performance of Oncoville.
Oncoville Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 180.43% increase. The company also saw a substantial improvement in profitability, with a 558.56% increase in profit. The company's net worth Soared by an impressive increase of 637.61%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Oncoville?
Unlock access to Oncoville's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Trimacs Healthcare LlpAnilkumar Gowda is a mutual person
Charges (Loans)
₹7.61 M
₹0
Charges Breakdown by Lending Institutions
- Axis Bank Limited : 0.76 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 18 Jan 2021 | Axis Bank Limited | ₹7.61 M | Open |
How Many Employees Work at Oncoville?
Oncoville has a workforce of 72 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Oncoville, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Oncoville's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.